Deccan Health Care Ltd
Incorporated in 1996, Deccan Healthcare Ltd is a manufacturer of Fast moving consumer health products[1]
- Market Cap ₹ 29.6 Cr.
- Current Price ₹ 11.9
- High / Low ₹ 20.0 / 6.65
- Stock P/E 12.7
- Book Value ₹ 44.5
- Dividend Yield 0.00 %
- ROCE 3.22 %
- ROE 2.21 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
- Stock is trading at 0.27 times its book value
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Promoter holding is low: 19.5%
- Company has a low return on equity of 1.71% over last 3 years.
- Contingent liabilities of Rs.18.7 Cr.
- Debtor days have increased from 72.9 to 97.1 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Healthcare Services Healthcare Service Provider
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2010 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 39.52 | 16.16 | 29.34 | 37.83 | 44.25 | 42.24 | 33.78 | 33.17 | 45.02 | 59.73 | 75.13 | 89.17 | 89.55 | |
| 38.54 | 9.81 | 16.54 | 23.77 | 27.44 | 30.57 | 31.74 | 27.54 | 42.97 | 55.97 | 71.95 | 84.15 | 84.55 | |
| Operating Profit | 0.98 | 6.35 | 12.80 | 14.06 | 16.81 | 11.67 | 2.04 | 5.63 | 2.05 | 3.76 | 3.18 | 5.02 | 5.00 |
| OPM % | 2.48% | 39.29% | 43.63% | 37.17% | 37.99% | 27.63% | 6.04% | 16.97% | 4.55% | 6.29% | 4.23% | 5.63% | 5.58% |
| 0.09 | -0.17 | 0.05 | 2.07 | 0.08 | 0.06 | 0.06 | -3.46 | 0.02 | 0.01 | 0.01 | -0.13 | 0.03 | |
| Interest | 0.10 | 1.48 | 2.14 | 1.50 | 1.04 | 0.18 | 0.11 | 0.15 | 0.11 | 0.06 | 0.07 | 0.37 | 0.50 |
| Depreciation | 0.22 | 1.15 | 1.19 | 1.28 | 1.29 | 1.42 | 1.47 | 1.47 | 1.43 | 1.47 | 1.45 | 1.46 | 1.45 |
| Profit before tax | 0.75 | 3.55 | 9.52 | 13.35 | 14.56 | 10.13 | 0.52 | 0.55 | 0.53 | 2.24 | 1.67 | 3.06 | 3.08 |
| Tax % | 30.67% | 0.28% | -0.21% | -0.15% | 0.62% | 0.39% | 25.00% | 40.00% | 26.42% | 32.59% | 28.14% | 25.16% | |
| 0.53 | 3.54 | 9.54 | 13.36 | 14.48 | 10.09 | 0.39 | 0.32 | 0.40 | 1.52 | 1.20 | 2.29 | 2.33 | |
| EPS in Rs | 0.99 | 3.39 | 7.38 | 9.90 | 9.22 | 6.42 | 0.25 | 0.20 | 0.23 | 0.75 | 0.51 | 0.93 | 0.93 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 19% |
| 5 Years: | 21% |
| 3 Years: | 26% |
| TTM: | 10% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | -4% |
| 5 Years: | 44% |
| 3 Years: | 81% |
| TTM: | 122% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | -15% |
| 3 Years: | -31% |
| 1 Year: | -39% |
| Return on Equity | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 2% |
| 3 Years: | 2% |
| Last Year: | 2% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2010 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 5.33 | 10.43 | 12.93 | 13.50 | 15.71 | 15.71 | 15.71 | 15.71 | 17.04 | 20.38 | 23.43 | 24.75 |
| Reserves | 11.08 | -2.03 | 9.21 | 32.68 | 50.43 | 60.52 | 60.91 | 61.23 | 64.61 | 76.66 | 83.13 | 85.47 |
| 10.46 | 13.94 | 10.94 | 10.90 | 1.41 | 1.30 | 1.03 | 1.25 | 1.55 | 1.41 | 1.15 | 3.96 | |
| 3.29 | 7.00 | 16.51 | 13.40 | 15.30 | 15.46 | 14.61 | 12.44 | 13.28 | 8.87 | 16.22 | 29.94 | |
| Total Liabilities | 30.16 | 29.34 | 49.59 | 70.48 | 82.85 | 92.99 | 92.26 | 90.63 | 96.48 | 107.32 | 123.93 | 144.12 |
| 18.54 | 17.12 | 17.32 | 17.71 | 20.85 | 21.25 | 19.87 | 18.53 | 16.85 | 15.69 | 14.38 | 15.02 | |
| CWIP | 0.00 | 0.00 | 0.00 | 3.51 | 0.00 | 0.00 | 0.07 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.02 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| 11.62 | 12.22 | 32.25 | 49.26 | 62.00 | 71.74 | 72.31 | 72.09 | 79.62 | 91.62 | 109.54 | 129.09 | |
| Total Assets | 30.16 | 29.34 | 49.59 | 70.48 | 82.85 | 92.99 | 92.26 | 90.63 | 96.48 | 107.32 | 123.93 | 144.12 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2010 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 3.04 | 2.28 | 12.92 | 2.62 | 2.68 | 0.22 | -0.57 | -6.59 | -12.48 | -6.60 | -3.59 | |
| 0.00 | 0.00 | -1.40 | -12.90 | -11.53 | -1.94 | -0.08 | -0.05 | 0.26 | -0.30 | -0.14 | -2.25 | |
| 0.00 | -2.91 | -0.95 | 0.21 | 13.07 | -1.77 | -0.37 | 0.07 | 5.06 | 13.64 | 8.01 | 3.97 | |
| Net Cash Flow | 0.00 | 0.13 | -0.08 | 0.23 | 4.16 | -1.03 | -0.23 | -0.55 | -1.27 | 0.86 | 1.27 | -1.87 |
| Free Cash Flow | 0.00 | 3.04 | 0.88 | 7.74 | 1.70 | 0.87 | 0.06 | -0.63 | -6.34 | -12.79 | -6.74 | -5.83 |
| CFO/OP | 0% | 48% | 18% | 92% | 16% | 23% | 18% | -6% | -311% | -332% | -207% | -71% |
Ratios
Standalone / View Consolidated
| Mar 2010 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 50.24 | 181.82 | 229.90 | 170.49 | 159.86 | 177.66 | 134.74 | 141.07 | 97.21 | 60.44 | 61.26 | 97.09 |
| Inventory Days | 34.08 | 269.62 | 432.36 | 596.97 | 773.64 | 825.88 | 890.81 | 1,182.75 | 683.64 | 445.05 | 326.33 | 239.32 |
| Days Payable | 31.06 | 264.36 | 447.94 | 173.22 | 185.88 | 153.84 | 112.09 | 146.00 | 123.28 | 41.39 | 68.52 | 99.44 |
| Cash Conversion Cycle | 53.25 | 187.08 | 214.32 | 594.24 | 747.62 | 849.70 | 913.46 | 1,177.82 | 657.58 | 464.10 | 319.07 | 236.98 |
| Working Capital Days | 51.72 | -155.17 | 193.82 | 240.82 | 321.94 | 421.77 | 545.99 | 603.01 | 502.26 | 477.19 | 423.69 | 384.77 |
| ROCE % | 5.08% | 42.08% | 32.94% | 25.03% | 14.21% | 0.81% | 5.62% | 0.79% | 2.53% | 1.69% | 3.22% |
Insights
In beta| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|
| Employee Count number |
|
|||||||
| Product Portfolio Count number |
||||||||
| E-commerce Consumer Base number |
||||||||
| Influencer / PIP Count number |
||||||||
| Foreign Distributors Count number |
||||||||
| Direct Wellness Consultants (DWC) Count number |
||||||||
| Home Shops (HS) Count number |
||||||||
| Number of States of Operation number |
||||||||
Extracted by Screener AI
Documents
Announcements
- Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
- Shareholder Meeting / Postal Ballot-Outcome of AGM
- Closure of Trading Window
-
Reg. 34 (1) Annual Report.
- Corporate/shareholder information and forward-looking statement disclaimer for Deccan Health Care Ltd.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
- Newspaper Clippings of 30th AGM Notice and E-Voting Information
Annual reports
-
Annual Report 2026
from bse
-
Annual Report 2025
from bse
-
Annual Report 2024
from bse
-
Annual Report 2023
from bse
-
Annual Report 2022
from bse
-
Annual Report 2021
from bse
-
Annual Report 2020
from bse
-
Annual Report 2019
from bse
Business Overview:[1]
DHL is a Nutraceutical and wellness product
company. Its food pills and meals are categorized
under Fast Moving Consumer Healthcare (FMCH) products and covers 52 consumer wellness goals preventing over 200 diseases, disorders and disabilities due to micro nutritional deficiency. Company does sales of its Be Young brand through e-commerce platform www.beyoungstore.com
In FY26, company launched functional foods,
fruit bars, gummies, personal/self-care, Weight
Wellness & Lifestyle Nutrition etc. and Wellness
Mart stores. Hydration and sports-nutrition were
under development.[2] [3]